The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective head-to-head comparison of 18F-fluciclovine and 68Ga-PSMA-11 PET/CT for localization of prostate cancer biochemical recurrence after primary prostatectomy.
 
Jeremie Calais
Stock and Other Ownership Interests - Endocyte
 
Francesco Ceci
No Relationships to Disclose
 
Kathleen Nguyen
No Relationships to Disclose
 
Jeannine Gartmann
No Relationships to Disclose
 
Matthias Eiber
Research Funding - Siemens
Travel, Accommodations, Expenses - Bayer Schering Pharma
 
Robert Evan Reiter
Stock and Other Ownership Interests - ImaginAb
Consulting or Advisory Role - Astellas Pharma
Speakers' Bureau - Genomic Health; ImaginAb; Janssen Oncology
Patents, Royalties, Other Intellectual Property - patents surrounding discovery of PSCA and N-cadherin, owned by UCLA (Inst)
 
Amar Upadhyaya Kishan
Honoraria - Varian Medical Systems; ViewRay; ViewRay
Consulting or Advisory Role - Janssen
 
Hossein Jadvar
No Relationships to Disclose
 
Wolfgang P Fendler
No Relationships to Disclose
 
Johannes Czernin
Employment - SOFIE (I)
Leadership - SOFIE; Trethera
Stock and Other Ownership Interests - SOFIE; Trethera
Consulting or Advisory Role - Actinium Medical Advisory Board
Research Funding - Endocyte (Inst)
Patents, Royalties, Other Intellectual Property - Trethera (Inst)